Eli Lilly’s Mounjaro Now Covered by China’s Health Insurance For Diabetes Treatment - Eli Lilly (NYSE:LLY), Novo Nordisk (NYSE:NVO)

Eli Lilly and Co. (NYSE:LLY) announced that its diabetes drug, Mounjaro, will be added to China’s state-run health insurance scheme from January 1, 2026.Mounjaro Added to China Reimbursement ListThe inclusion of Mounjaro on China’s national reimbursement list, as decided by its National Healthcare Security Administration (NHSA) on Sunday, will make the drug more accessible to the public.However, the move could also drive down selling prices. Mounjaro, a once-weekly injectable treatment, entered the Chinese ...